We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$396M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.28%
Holding
1,311
New
31
Increased
615
Reduced
268
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 59.19%
2 Technology 7.88%
3 Communication Services 4.43%
4 Consumer Discretionary 3.51%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALV
1176
DELISTED
KalVista Pharmaceuticals
KALV
$1K ﹤0.01%
46
KNSA icon
1177
Kiniksa Pharmaceuticals
KNSA
$4.88B
$1K ﹤0.01%
60
KPTI icon
1178
Karyopharm Therapeutics
KPTI
$168M
$1K ﹤0.01%
9
KRRO icon
1179
Korro Bio
KRRO
$150M
$1K ﹤0.01%
1
MGTX icon
1180
MeiraGTx Holdings
MGTX
$1.14B
$1K ﹤0.01%
82
NGNE icon
1181
Neurogene
NGNE
$682M
$1K ﹤0.01%
4
ORIC icon
1182
Oric Pharmaceuticals
ORIC
$1.24B
$1K ﹤0.01%
69
PAHC icon
1183
Phibro Animal Health
PAHC
$1.42B
$1K ﹤0.01%
38
PASG icon
1184
Passage Bio
PASG
$15.4M
$1K ﹤0.01%
4
PBYI icon
1185
Puma Biotechnology
PBYI
$413M
$1K ﹤0.01%
87
RAPT
1186
DELISTED
RAPT Therapeutics
RAPT
$1K ﹤0.01%
6
RLMD icon
1187
Relmada Therapeutics
RLMD
$547M
$1K ﹤0.01%
31
RNAC icon
1188
Cartesian Therapeutics
RNAC
$237M
$1K ﹤0.01%
7
SIGA icon
1189
SIGA Technologies
SIGA
$229M
$1K ﹤0.01%
172
SMMT icon
1190
Summit Therapeutics
SMMT
$10.8B
$1K ﹤0.01%
155
SNAP icon
1191
PUT
Snap
SNAP
$7.59B
$1K ﹤0.01%
1,085
SPRO icon
1192
Spero Therapeutics
SPRO
$70.1M
$1K ﹤0.01%
51
SYRE icon
1193
Spyre Therapeutics
SYRE
$8.62B
$1K ﹤0.01%
4
TCRT icon
1194
Alaunos Therapeutics
TCRT
$4.71M
$1K ﹤0.01%
3
TXMD icon
1195
TherapeuticsMD
TXMD
$24M
$1K ﹤0.01%
12
UBX
1196
DELISTED
Unity Biotechnology
UBX
$1K ﹤0.01%
12
URGN icon
1197
UroGen Pharma
URGN
$1.98B
$1K ﹤0.01%
48
VSTM icon
1198
Verastem
VSTM
$552M
$1K ﹤0.01%
27
WVE icon
1199
Wave Life Sciences
WVE
$1.14B
$1K ﹤0.01%
99
XBIT icon
1200
XBiotech
XBIT
$68.9M
$1K ﹤0.01%
64

Similar funds

Daiwa Securities Group's Q2 2021 Portfolio in Review

As of Q2 2021, Daiwa Securities Group held 1,311 positions worth $14.8B, up 10% from $13.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q2 2021 filing shows 31 new, 615 increased, 268 reduced and 37 closed positions. Its largest new stake was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M. The largest sale was Invitation Homes, an estimated $172M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2021 buy was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M.
  • Daiwa Securities Group added most to AvalonBay Communities in Q2 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $172M.
  • Daiwa Securities Group fully exited Global X Cloud Computing ETF in Q2 2021, selling an estimated $29.5M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $14.8B portfolio in Q2 2021.
  • Daiwa Securities Group opened 31 new positions and closed 37 in Q2 2021.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.